GlassScriptPhysician profile
Anthony P Caruso
NPI 1013913938
$7,131.71
in general payments reported to CMS, 2019-2025
48 companies · $1,704 in 2025
The $1,704 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,145 · 2020: $396 · 2021: $623 · 2022: $1,232 · 2023: $867 · 2024: $1,165 · 2025: $1,704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,537 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,537.03 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,197.79 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $624.37 | 2019-2025 | Erleada |
| Coloplast Corp | $423.26 | 2019-2024 | Porges Coloplast |
| Boston Scientific Corporation | $361.14 | 2019-2025 | Advantage System, Rezum Generator, General - Kidney Stone Disease |
| Dendreon Pharmaceuticals LLC | $359.79 | 2019-2025 | Provenge |
| Pfizer INC. | $330.22 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $326.60 | 2019-2023 | |
| Abbvie INC. | $291.12 | 2020-2025 | |
| Urogen Pharma, INC. | $204.47 | 2021-2024 | |
| Antares Pharma, INC. | $180.45 | 2019-2025 | Xyosted |
| Sumitomo Pharma America, INC. | $177.66 | 2025 | Gemtesa |
| Myriad Genetic Laboratories, INC. | $163.92 | 2021-2025 | Prolaris |
| Merck Sharp & Dohme LLC | $157.43 | 2024-2025 | Lynparza, Keytruda |
| Ferring Pharmaceuticals INC. | $151.48 | 2019-2025 | Adstiladrin |
| C. R. Bard, INC. & Subsidiaries | $140.01 | 2019-2025 | Bard Urinary Drainage Bag |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $139.46 | 2019-2024 | Xiaflex |
| Verity Pharmaceuticals INC. | $128.72 | 2024-2025 | Trelstar |
| Sun Pharmaceutical Industries INC. | $119.48 | 2019-2024 | Yonsa |
| Procept Biorobotics Corporation | $107.95 | 2025 | |
| Myovant Sciences INC. | $106.17 | 2021-2022 | |
| Endo USA, INC. | $102.93 | 2024-2025 | Xiaflex, Aveed |
| Astrazeneca Pharmaceuticals LP | $99.31 | 2022-2025 | Lynparza, Faslodex |
| Accord Healthcare, INC. | $98.85 | 2023-2024 | |
| 180 Medical, INC. | $98.69 | 2022-2025 | Cure Ultra Catheter |
| Tolmar, INC. | $92.97 | 2023 | |
| Progenics Pharmaceuticals, INC. | $82.46 | 2022-2025 | |
| Rochester Medical Corporation | $77.09 | 2022 | |
| Teleflex LLC | $75.96 | 2025 | Urolift, Deknatel |
| Bluewind Medical | $72.83 | 2025 | Revi |
| Convatec INC. | $71.20 | 2025 | |
| Novartis Pharmaceuticals Corporation | $68.98 | 2023-2025 | |
| Laborie Medical Technologies Corp. | $65.98 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Olympus America INC. | $62.38 | 2025 | Itind System |
| Immunitybio, INC. | $48.59 | 2024-2025 | |
| Urovant Sciences INC | $45.99 | 2022 | |
| Baxter Healthcare | $42.63 | 2023-2025 | Tisseel |
| Therapeuticsmd, INC. | $36.23 | 2019 | |
| Janssen Scientific Affairs, LLC | $26.95 | 2019 | |
| Calyxo, INC. | $21.15 | 2024 | Cvac Aspiration System |
| Palette Life Sciences, INC. | $20.45 | 2023 | |
| Smith+Nephew, INC. | $18.47 | 2022 | |
| Agiliti Surgical, INC. | $18.42 | 2024 | Sonablate Hifu |
| Tolmar Pharmaceuticals, INC. | $18.13 | 2022 | |
| Cook Medical LLC | $17.53 | 2019 | |
| Ambu INC. | $17.29 | 2022 | |
| Profound Medical Corp. | $15.91 | 2025 | Tulsa-Pro |
| Travere Therapeutics, INC. | $12.77 | 2019-2021 | |
| Amniox Medical, INC. | $10.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Caruso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.